Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()

Radiotherapy (XRT) delivered with the antibody cetuximab is a standard treatment option for squamous cell carcinomas of head and neck (SCCNH). Cetuximab acts by blocking epidermal growth factor receptor (EGFR) signaling to inhibit cancer progression. However, a significant percentage of patients wil...

Descripción completa

Detalles Bibliográficos
Autores principales: de Llobet, Lara I., Baro, Marta, Mesia, Ricard, Balart, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202798/
https://www.ncbi.nlm.nih.gov/pubmed/25171892
http://dx.doi.org/10.1016/j.tranon.2014.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202798/
https://www.ncbi.nlm.nih.gov/pubmed/25171892
http://dx.doi.org/10.1016/j.tranon.2014.02.008

Ejemplares similares